The current state of cardiology in China

Abstract Cardiology in China has shown significant changes in the last decade or so. Interventional cardiology, in particular, has shown remarkable advances, especially in the management of coronary artery disease, which, unfortunately, has shown a disconcerting increase in incidence in a country traditionally known for very low incidence of coronary artery disease. Important contributing factors include increasing affluence, westernization of dietary habit and lifestyle, and rampant cigarette smoking. At present, the Chinese population has an annual coronary mortality of one sixth of that reported in the West, an incidence of acute myocardial infarction of one tenth to one eighth, and a mortality of acute myocardial infarction of one eighth. The prevalence of coronary artery disease among the general Chinese population (3–7%) is roughly one quarter of that among the Caucasians in the West, but this will get worse for sure. China still has a lot of catching up to do to reach full modernization. There is a price that every developing country must pay for modernization. However, let the price the Chinese pay not exceed the benefits derived from modernization. Can we achieve a utopian stage in the 21st century in which the modern Chinese retain their ancestral low rates of coronary artery disease while adapting the positive aspects of a modern western lifestyle?

[1]  Ying Li,et al.  Overweight is an independent risk factor for cardiovascular disease in Chinese populations , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[2]  H. Russek.  New horizons in cardiovascular practice , 1975 .

[3]  T. Cheng.  Chinese last name comes first. , 1995, International journal of cardiology.

[4]  T. Cheng,et al.  Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center. , 2004, International journal of cardiology.

[5]  Y. Hu,et al.  Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[6]  J. Menke.  Herbal remedies. , 1997, South Dakota journal of medicine.

[7]  T. Cheng,et al.  Acronyms of cardiologic trials--2002. , 2003, International journal of cardiology.

[8]  W. Edwards.  Quadricuspid aortic valve with centrally fenestrated leaflets. , 1989, Texas Heart Institute journal.

[9]  L. Fleisher,et al.  Treatment of coronary artery disease in the year 2003. , 2003, Journal of Cardiothoracic and Vascular Anesthesia.

[10]  C. To,et al.  Percutaneous balloon mitral valvuloplasty by the Inoue balloon technique: the procedure of choice for treatment of mitral stenosis. , 1998, The American journal of cardiology.

[11]  T. Cheng.  Interaction of herbal medicine with Coumadin. , 2000, The Journal of emergency medicine.

[12]  D. Coltart.  The International Textbook of Cardiology , 1988 .

[13]  T. Cheng.  RE: “USE OF SURNAMES TO IDENTIFY INDIVIDUALS OF CHINESE ANCESTRY” , 1994 .

[14]  T. Cheng.  Panax (ginseng) is not a panacea. , 2000, Archives of internal medicine.

[15]  S. Qiao,et al.  [Complications in selective coronary angiography: analysis of 9196 cases]. , 2003, Zhonghua yi xue za zhi.

[16]  G. Ma,et al.  Effect of television viewing on pediatric obesity. , 2002, Biomedical and environmental sciences : BES.

[17]  T. Lam,et al.  Mortality attributable to cigarette smoking in China. , 1997, JAMA.

[18]  T. Cheng.  Cardiovascular disease in China , 1998, Nature Medicine.

[19]  T. Cheng.  Coronary heart disease in China. , 1999, Hospital medicine.

[20]  T. Cheng.  Fast food and obesity in China. , 2003, Journal of the American College of Cardiology.

[21]  T O Cheng,et al.  Teenage smoking in China. , 1999, Journal of adolescence.

[22]  T. Cheng.  Warfarin danshen interaction. , 1999, The Annals of thoracic surgery.

[23]  T. Cheng.  Price of modernization of China. , 2001, Circulation.

[24]  Michael R Phillips,et al.  Suicide rates in China, 1995–99 , 2002, The Lancet.

[25]  F. P. Koisch,et al.  Medical aspects of competitive distance running: guidelines for community physicians. , 1981, Postgraduate medicine.

[26]  J. R. Quinn.  China medicine as we saw it , 1974 .

[27]  R. Merritt.  Treatment of pediatric and adolescent obesity. , 1978, International journal of obesity.

[28]  J. Chan,et al.  Smoking and diabetes in Chinese men , 2001, Postgraduate medical journal.

[29]  V. Ambruso,et al.  Acupuncture anesthesia. , 1974, International surgery.

[30]  T. Cheng.  A view of modern Chinese medicine. Observations by a Shanghai-born physician during his recent visit after 22 years of absence. , 1973, Annals of internal medicine.

[31]  E. Janus,et al.  The emergence of coronary heart disease in populations of Chinese descent. , 2003, Atherosclerosis.

[32]  J Mervis.  Epidemiology: China's Unique Environment Favors Large Intervention Trials , 1995, Science.

[33]  T. Lam,et al.  A review on studies of smoking and coronary heart disease in China and Hong Kong. , 1999, Chinese medical journal.

[34]  B. Popkin,et al.  The obesity epidemic is a worldwide phenomenon. , 2009, Nutrition reviews.

[35]  R. Luan,et al.  [Meta-analysis of risk factor on hypertension in China]. , 2003, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[36]  J Maddox.  The great leap forward , 1994, Nature.

[37]  Banerjee Ak.  Posterior leukoencephalopathy syndrome , 2001 .

[38]  T. Cheng.  Do photographs lie? Smoking in China. , 1992, The gerontologist.

[39]  T. Cheng,et al.  Late results of percutaneous balloon mitral valvuloplasty: the Chinese experience. , 2000, Circulation.

[40]  T. Cheng.  St John's wort interaction with digoxin. , 2000, Archives of internal medicine.

[41]  K. Coyne,et al.  A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. , 2001, American heart journal.

[42]  T. Cheng,et al.  Percutaneous balloon mitral valvuloplasty by the Inoue technique: a multicenter study of 4832 patients in China. , 1995, American heart journal.

[43]  T. Cheng.  Ginseng-Warfarin interaction , 2000 .

[44]  Dennis Normile.  Beijing Genomics Institute: From Standing Start to Sequencing Superpower , 2002, Science.

[45]  A data analysis of the Third National Coronary Intervention Registry , 2002 .

[46]  T. Cheng.  Interaction of herbal drugs with digoxin. , 2002, Journal of the American College of Cardiology.

[47]  T. Cheng.  Conundrum of the “French Paradox” , 2001 .

[48]  T O Cheng,et al.  Acronyms of clinical trials in cardiology--1998. , 1999, American heart journal.

[49]  A. Tinker.  Institutional abuse of older people. , 1999, Hospital medicine.

[50]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[51]  A. Pichard,et al.  Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. II. An analysis of 218 deaths related to coronary arteriography. , 1989, Catheterization and cardiovascular diagnosis.

[52]  T. Cheng.  Herbal interactions with cardiac drugs. , 2000, Archives of internal medicine.

[53]  D. Topping,et al.  Smoking and health , 1984, The Medical journal of Australia.

[54]  T. Cheng.  Cardiology in China revisited , 1978 .

[55]  T. Cheng.  The Chinese last name , 1988 .

[56]  T. O. Cheng.  Word order: oriental or occidental? , 1989, Texas Heart Institute Journal.

[57]  Robert R. L. Smith,et al.  Results and Complications , 1994 .

[58]  Q Wang,et al.  Research design and statistical methods in Chinese medical journals. , 1998, JAMA.

[59]  H Lurie,et al.  Electric power research. , 1973, Science.

[60]  B. C. Choi,et al.  Use of surnames to identify individuals of Chinese ancestry. , 1993, American journal of epidemiology.

[61]  T. Cheng.  Comment: Drug—Herb Interaction , 2001, The Annals of pharmacotherapy.

[62]  J. Torpy,et al.  JAMA patient page. Obesity. , 2003, Journal of the American Medical Association (JAMA).

[63]  R Peto,et al.  Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. , 1991, BMJ.

[64]  B. Popkin,et al.  What is China doing in policy-making to push back the negative aspects of the nutrition transition? , 2002, Public Health Nutrition.

[65]  A. Pichard,et al.  Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications. , 1989, Catheterization and cardiovascular diagnosis.

[66]  B. Popkin,et al.  A new stage of the nutrition transition in China , 2002, Public Health Nutrition.

[67]  Yan Shen,et al.  Extensive Association Analysis Between Polymorphisms of PON Gene Cluster With Coronary Heart Disease in Chinese Han Population , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[68]  T. Cheng.  Acronyms of clinical trials in cardiology--1994. , 1994, The American journal of cardiology.

[69]  K. Shirato,et al.  [Diagnosis and treatment of pulmonary thromboembolism]. , 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[70]  W. Jia,et al.  Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[71]  T. Cheng.  What's In A Name — The Chinese Name? , 1989 .

[72]  G. Burch.  [Cardiovascular diseases]. , 1956, Revista medica cubana.

[73]  T. Cheng,et al.  Experimental study of relationship between intracoronary alcohol injection and the size of resultant myocardial infarct. , 2003, International journal of cardiology.